A phase Ib dose-escalation study of ZN-c3, a WEE1 inhibitor, in combination with chemotherapy in patients with platinum-resistant or -refractory ovarian, peritoneal, or fallopian tube cancer

S. Fu, A. Pasic, G. Richardson, Z. J. Vranjes, T. Meniawy, P. R. de Jong, F. Donate, A. A. Samatar, J. Rodriguez, P. Pultar, D. Voliotis

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S618-S618
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - 2021
EventCongress of the European-Society-for-Medical-Oncology (ESMO) -
Duration: 16 Sep 202121 Sep 2021

Cite this